4411 | VOIS 003 X 0031 | kaiser | 03/27/2015 10:34:43 AM |
4381 | GEQU 006 | kaiser | 03/17/2015 11:10:12 AM |
4380 | MGON 0011 X 0012 | kaiser | 03/17/2015 10:45:11 AM |
4379 | GEQU 0039 X 0043 | kaiser | 03/17/2015 9:49:02 AM |
4378 | GEQU 004 nice news out yesterday. | kaiser | 03/17/2015 9:22:59 AM |
4377 | MGON 0016 looks ready to move over | kaiser | 03/16/2015 11:49:37 AM |
4376 | MCGI 0038 X 0042 | kaiser | 03/13/2015 2:21:06 PM |
4375 | JALA 0085 | kaiser | 03/13/2015 2:02:17 PM |
4374 | JALA 0081 X 0083 | kaiser | 03/13/2015 1:09:33 PM |
4373 | IDVC 0012 buys coming in | kaiser | 03/13/2015 12:30:53 PM |
4372 | JALA 0082 | kaiser | 03/13/2015 12:15:41 PM |
4371 | JALA 0075 X 008 | kaiser | 03/13/2015 11:34:09 AM |
4370 | MCGI 0038 | kaiser | 03/13/2015 11:18:59 AM |
4369 | MCGI 0036 hitting | kaiser | 03/13/2015 11:08:51 AM |
4368 | JALA 0077 | kaiser | 03/13/2015 10:51:33 AM |
4367 | TPAC 0014 | kaiser | 03/13/2015 10:50:43 AM |
4366 | TPAC 0013 | kaiser | 03/13/2015 10:12:49 AM |
4365 | JALA 0076 | kaiser | 03/13/2015 10:12:21 AM |
4364 | VOIS 0044 | kaiser | 03/13/2015 10:11:06 AM |
4363 | VOIS 0043 company should have news coming | kaiser | 03/13/2015 9:53:35 AM |
4362 | TPAC 0012 nice buys coming in | kaiser | 03/13/2015 9:48:03 AM |
4361 | MCGI 0036 | kaiser | 03/13/2015 9:33:13 AM |
4360 | JALA 0065 X 0069 | kaiser | 03/10/2015 1:40:23 PM |
4359 | JALA 0065 | kaiser | 03/10/2015 1:05:58 PM |
4358 | RCGP 0025 X 003 | kaiser | 03/10/2015 1:03:09 PM |
4357 | MCGI 0023 | kaiser | 03/10/2015 11:56:54 AM |
4356 | JALA 0064 X 0066 | kaiser | 03/10/2015 11:16:16 AM |
4355 | JALA 0062 should move back up from | kaiser | 03/10/2015 11:00:34 AM |
4354 | MCGI 0018 | kaiser | 03/10/2015 10:22:29 AM |
4353 | MCGI 0016 | kaiser | 03/10/2015 10:16:07 AM |
4352 | TINO 0067 X 0069 | kaiser | 03/09/2015 3:07:28 PM |
4351 | MCGI 002 | kaiser | 03/09/2015 2:06:56 PM |
4350 | MCGI 0014 nice buys coming in | kaiser | 03/09/2015 1:49:13 PM |
4349 | TINO 0064 X 0067 | kaiser | 03/09/2015 1:16:08 PM |
4348 | JALA 0086 | kaiser | 03/06/2015 1:36:02 PM |
4347 | JALA 008 | kaiser | 03/06/2015 1:14:19 PM |
4346 | JALA 0075 | kaiser | 03/06/2015 12:39:19 PM |
4345 | JALA 0074 | kaiser | 03/06/2015 11:52:05 AM |
4344 | JALA 007 | kaiser | 03/06/2015 11:48:01 AM |
4343 | JALA 0061 X 0063 | kaiser | 03/06/2015 11:22:06 AM |
4342 | JALA 0058 | kaiser | 03/06/2015 10:04:58 AM |
4341 | JALA 005 X 0054 | kaiser | 03/06/2015 9:53:48 AM |
4340 | JALA 0048 | kaiser | 03/06/2015 9:49:38 AM |
4339 | TINO 006 | kaiser | 03/06/2015 9:39:48 AM |
4338 | JALA 0047 | kaiser | 03/06/2015 9:36:18 AM |
4337 | TINO 0058 | kaiser | 03/06/2015 9:35:12 AM |
4336 | JALA 0043 | kaiser | 03/05/2015 3:37:40 PM |
4335 | TINO 0056 | kaiser | 03/05/2015 3:17:38 PM |
4334 | TINO 0053 | kaiser | 03/05/2015 3:02:41 PM |
4333 | TINO 005 | kaiser | 03/05/2015 2:59:42 PM |
4332 | JALA 0036 X 0042 nice buying | kaiser | 03/05/2015 12:42:21 PM |
Recent Articles
- Class Action Alert: Reddit Investors Must Act Before Deadline
- Understanding the Legal Activity Surrounding Hims Inc. Shares
- Sarepta Therapeutics Faces Lawsuit: Take Action Before Deadline
- Alto Neuroscience Shareholder Class Action: Important Updates
- Datumo's $15.5 Million Fund Boosts AI Evaluation Tools
- IRS Clarifies No New Stimulus Checks Will Be Issued This Year
- CTO Realty Growth Investors: Act Now for Class Action Rights
- Danielle Panabaker's Crossover Experience: Pay Issues Revealed
- New Forever Stamp Celebrates Legacy of Former President Carter
- XPPen Marks 20 Years of Innovation and Creativity in Art
- Investigation Launched for Investors of GSK plc Amid Concerns
- Unraveling Investor Concerns Involving Confluent, Inc. Stock
- Investigation into Neogen Corporation Raises Concerns for Investors
- Class Action Filed Against Alto Neuroscience Over IPO Misrepresentation
- Class Action Lawsuit Announced Against Hims & Hers Health, Inc.
- Understanding the Legal Landscape for PetMed Investors
- Class Action Filed Against Flywire Corporation: A Legal Overview
- Investigation into Unicycive Therapeutics Raises Consumer Concerns
- Join the Class Action Against XPLR Infrastructure: Your Rights Matter
- Dyne Therapeutics Faces Investigations Over Alleged Fraud Claims
- iRobot Faces Class Action Lawsuit as Investor Confidence Wanes
- Ricardo Salinas Plans Full Bitcoin Investment Strategy
- Investigation Announced for Geely Automobile Holdings Investors
- Capricor Therapeutics Faces Investigation Amid Stock Concerns
- Important Updates for Investors in Fiserv, Inc. Lawsuit
- Investors Alerted: Class Action Lawsuit Against RxSight, Inc.
- Reddit Faces Legal Action Amidst Declining User Rates
- Major Class Action Opportunity for Charter Communications Investors
- Understanding the Replimune Group Class Action Lawsuit Process
- Trump and Putin: A Controversial Conversation on Election Integrity
- Investors Alert: Class Action Filed Against Biohaven Ltd.
- Investigation into Barnes & Noble Education Sparks Concern
- Simulations Plus Faces Scrutiny Amidst Financial Challenges
- Tesla Faces Class Action Lawsuit Amidst Controversial Robotaxi Launch
- Exploring Legal Investigations into Dow Inc. for Investors
- Investigation into Tronox Holdings: Examining Recent Developments
- Albany International Corp. Faces Investor Scrutiny Amid Concerns
- Inspire Medical Systems on the Radar as Stock Drops Significantly
- Spectrum Pharmaceuticals Faces Class Action Lawsuit Reminder
- Lockheed Martin Faces Class Action Amidst Losses and Lawsuit
- Mohamed bin Zayed University Welcomes Record Student Cohort
- What is Ethereum? A Simple Guide for New Crypto Users
- Investigation into Altimmune, Inc. Potential Securities Violations
- American Outdoor Brands: Investigating Claims For Investors
- Investigation into BellRing Brands, Inc. Raises Concerns for Investors
- Investor Insights: Harrow Inc. Investigated for Securities Fraud
- Investigation into Funko, Inc. by Pomerantz Law Firm
- Investors Urged to Learn About Mereo BioPharma's Situation
- Investigation into Charter Communications Raises Concerns
- Investor Concerns Grow for Anika Therapeutics Amid Legal Scrutiny